Navigation Links
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Date:5/31/2008

ttp://www.millennium.com" target="_new">http://www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and development of products. Various important risks may cause the Company's actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contacts:

Jennifer Snyder Karen Gobler

(617) 444-1439 (617) 444-1392


'/>"/>
SOURCE Millennium Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
3. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
4. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
5. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
6. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
7. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
8. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
11. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 Biobanks - How to ... ,Are you interested in the future ... technological and commercial predictions from 2015. You stay ahead ... research and development, results, opportunities and revenue forecasts. ... you what,s possible for biobanking and associated technology to ...
(Date:7/7/2015)... BURLINGTON, Mass. , July 7, 2015 /PRNewswire/ ... are similarities and differences in dialysis patient management ... based on information submitted by U.S. and EU5 ... ESAs and phosphate binders are the most commonly ... use of IV iron differs considerably between the ...
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... Quarter and Fiscal Year 2015 on Wednesday, August 5 th ... announcement will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live ... , 2015 to discuss the results.  To access the webcast, ...
Breaking Medicine Technology:Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2
(Date:7/7/2015)... ... July 07, 2015 , ... Researchers at UC ... what worked (or didn’t) and how similar programs can be improved. , Interviewing ... Living TeleHealth Community of Practice (HEALTH COP) program, the team identified four factors ...
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a ... launched their first line of luxury smart jewelry called the Socialite™ collection. The ... ship this fall. , “The Socialite collection was crafted to inspire women ...
(Date:7/7/2015)... ... 2015 , ... Dermatologists from the Mount Sinai Health System ... possible melanomas and 46 potential non-melanoma skin cancers (basal cell and squamous cell ... Ideas Festival, which was held from June 25 through July 4, 2015, in ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... announced today that the two firms have merged to form Camber Collective. ... and biopharma sectors. The merger combines SwitchPoint’s strategy consulting expertise with Hope ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... group whose board is limited to permit holders. The Medical Cannabis Alliance of ... move the industry forward and are committed to making sure patients have access ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2
... 11 The Chasen Group ... ergonomic interventions to prevent workplace injuries, increase employee ... Wiley and Sons, the foremost publisher of scientific ... "Safety Manager,s Guide to Office Ergonomics," written by ...
... an invited panelist in the second annual SOA in Healthcare conference to ... ... Plano, Texas (PRWEB) May 11, 2009-- Corepoint Health,s CTO, Dave Shaver, will ... to be held on June 2 - 4 in Chicago, Illinois. ...
... new alternative for patientsRESEARCH TRIANGLE PARK, N.C., May 11 ... that the U.S. Food and Drug Administration (FDA) has ... ODT uses a novel drug-delivery formulation to provide ... pleasant taste and disintegrates on the tongue. One ...
... RAPIDS, Mich., May 11 Lambert, Edwards ... Inc. to its growing roster of health care clients.Aspirus ... Wis. providing health care services to residents in north-central ... Aspirus Wausau Hospital is consistently recognized as one of ...
... ProCitius Research jointly announce a strategic alliance created to provide clients ... ... Toronto, Canada and Chennai, India (PRWEB) - Dalton Pharma Services and ... with contract chemistry services of exceptional value. , ...
... During National Women,s Health Week Points to Importance of ... today on gender-based differences in mental health shows women ... from major depression. The report addresses many other ... and violence can have on long term mental health, ...
Cached Medicine News:Health News:Office Ergonomics Book Reveals Early-Stage Solutions 2Health News:Corepoint Health CTO to Participate in Panel Discussion at the 2009 SOA in Healthcare Conference 2Health News:Corepoint Health CTO to Participate in Panel Discussion at the 2009 SOA in Healthcare Conference 3Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 2Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 3Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 4Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 5Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 6Health News:Lambert, Edwards & Associates Named Agency of Record for Aspirus, Inc. 2Health News:Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 2Health News:Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 3Health News:Women at Greater Risk for Depression and Anxiety 2Health News:Women at Greater Risk for Depression and Anxiety 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: